Amicus Therapeutics, Inc. Logo

Email this page: News Release

Amicus Therapeutics and GlaxoSmithKline Expand Fabry Disease Collaboration

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Amicus Therapeutics, Inc. for any marketing purposes.

Send:       


 
This helps Amicus Therapeutics, Inc. prevent automated submissions.